MS/Vitamin D Trial: A randomized controlled trial of vitamin D supplementation in multiple sclerosis
Low vitamin D levels have been shown to increase a person’s risk of developing multiple sclerosis (MS), and patients with MS who have lower vitamin D levels are at increased risk of having attacks.  In this clinical trial, patients with relapsing-remitting MS will receive high-dose or low-dose oral vitamin D in addition to an approved therapy for MS, glatiramer acetate. Patients will be evaluated for two years, and the effect of high-dose vitamin D supplementation on the rate of MS attacks and on the number of new lesions and change in brain volume on MRI will be determined
Website:  http://clinicaltrials.gov/ct2/show/NCT01490502
Principal Investigator:  Arash Farhadi,
Research Coordinator:  Carol Bell, RN  (443) 481-5891